European Medicines Agency
- All
- News
- Videos
-
European Watchdog Partially Approves New Alzheimer's Drug
Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer's disease, reversing an earlier decision not to give it the green light.
-
EU Regulator Backs Use Of Novavax Covid Shot As A Booster
The European Medicines Agency (EMA) on Thursday backed the use of Novavax's COVID-19 shot as a booster for adults, ahead of an anticipated rise in infections this winter.
-
"No Time To Lose": EU's Nod To 2nd Covid Booster Jab For People Over 60
The EU's health and medicine agencies said Monday they were recommending a second booster shot of a Covid vaccine for people over 60 years old, as infections rise again.
-
EU Drug Regulator Reviews Use Of Smallpox Vaccine Against Monkeypox
Monkeypox Virus: The European Union's drug regulator European Medicines Agency said it had started formally reviewing the use of a smallpox vaccine Imvanex to treat a growing number of cases of monkeypox.
-
Pfizer Covid Pill Europe's First Approved Oral Treatment Against Covid
The EU's drug watchdog approved Pfizer's coronavirus pill on Thursday, making it the first oral antiviral treatment for the disease to be authorised in Europe.
-
WHO Approves Novavax As 10th Authorised Covid Jab
The World Health Organization on Tuesday approved a Covid vaccine made by US pharma giant Novavax for emergency use, after the European Union medicines regulator gave it the green light.
-
Novavax Covid Vaccine Could Gain European, WHO Approval Next Week: Report
Novavax's covid vaccine could receive approval from Europe's drug regulator next week and subsequently an emergency use listing from the WHO, the Financial Times reported on Thursday
-
Johnson & Johnson Covid Vaccine Can Be Used As Booster: EU Medical Body
The European Medicines Agency said Wednesday that Johnson & Johnson's Covid vaccine can be used as a booster shot two months after the first dose was administered, or after receiving other mRNA shots.
-
Omicron Cases So Far Appear "Mostly Mild": European Medicines Agency
The European Medicines Agency (EMA) said Thursday that cases of Omicron so far appear to be "mostly mild", but cautioned it was still investigating whether the variant could cause severe disease.
-
Too Early To Know If New Covid Variant Needs New Vaccine: EU Medical Body
The EU's drug regulator said on Friday that it was closely monitoring the new B.1.1.529 Covid-19 variant, but it was too soon to tell if updated vaccines would be needed.
-
Moderna Seeks EU Approval Of Covid Vaccine For 6 To 11 Year Olds
Moderna has applied to the European Union's medicine regulator for approval of its Covid-19 vaccine for children aged six to 11, the US biotechnology company announced Tuesday.
-
European Union To Approve First Covid Antibody Drugs Amid Spike In Cases
The European Union drugs regulator is set to authorise the use of two monoclonal antibodies to treat COVID-19 patients in coming days, two EU sources told Reuters, in its first approvals of such therapies.
-
Pfizer Submits Data For Approval Of Covid Jab For Ages 5 To 11 In Europe
Pfizer and BioNTech said Friday they had submitted data to the EU's medicines watchdog for the approval of their coronavirus vaccine for children aged 5 to 11, following a similar step in the United States.
-
Nerve Disorder Listed As "Very Rare" Side Effect Of AstraZeneca Vaccine
The European Medicines Agency has listed the neurological disorder Guillain-Barre syndrome, which can cause temporary paralysis, as a "very rare" side effect of the AstraZeneca Covid-19 vaccine.
-
No Application Received For Covishield Authorisation, Says EU Medical Body
The European Medicines Agency (EMA) has not received any application from the Serum Institute of India for authorisation of Covishield, a COVID-19 vaccine.
-
European Watchdog Partially Approves New Alzheimer's Drug
Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer's disease, reversing an earlier decision not to give it the green light.
-
EU Regulator Backs Use Of Novavax Covid Shot As A Booster
The European Medicines Agency (EMA) on Thursday backed the use of Novavax's COVID-19 shot as a booster for adults, ahead of an anticipated rise in infections this winter.
-
"No Time To Lose": EU's Nod To 2nd Covid Booster Jab For People Over 60
The EU's health and medicine agencies said Monday they were recommending a second booster shot of a Covid vaccine for people over 60 years old, as infections rise again.
-
EU Drug Regulator Reviews Use Of Smallpox Vaccine Against Monkeypox
Monkeypox Virus: The European Union's drug regulator European Medicines Agency said it had started formally reviewing the use of a smallpox vaccine Imvanex to treat a growing number of cases of monkeypox.
-
Pfizer Covid Pill Europe's First Approved Oral Treatment Against Covid
The EU's drug watchdog approved Pfizer's coronavirus pill on Thursday, making it the first oral antiviral treatment for the disease to be authorised in Europe.
-
WHO Approves Novavax As 10th Authorised Covid Jab
The World Health Organization on Tuesday approved a Covid vaccine made by US pharma giant Novavax for emergency use, after the European Union medicines regulator gave it the green light.
-
Novavax Covid Vaccine Could Gain European, WHO Approval Next Week: Report
Novavax's covid vaccine could receive approval from Europe's drug regulator next week and subsequently an emergency use listing from the WHO, the Financial Times reported on Thursday
-
Johnson & Johnson Covid Vaccine Can Be Used As Booster: EU Medical Body
The European Medicines Agency said Wednesday that Johnson & Johnson's Covid vaccine can be used as a booster shot two months after the first dose was administered, or after receiving other mRNA shots.
-
Omicron Cases So Far Appear "Mostly Mild": European Medicines Agency
The European Medicines Agency (EMA) said Thursday that cases of Omicron so far appear to be "mostly mild", but cautioned it was still investigating whether the variant could cause severe disease.
-
Too Early To Know If New Covid Variant Needs New Vaccine: EU Medical Body
The EU's drug regulator said on Friday that it was closely monitoring the new B.1.1.529 Covid-19 variant, but it was too soon to tell if updated vaccines would be needed.
-
Moderna Seeks EU Approval Of Covid Vaccine For 6 To 11 Year Olds
Moderna has applied to the European Union's medicine regulator for approval of its Covid-19 vaccine for children aged six to 11, the US biotechnology company announced Tuesday.
-
European Union To Approve First Covid Antibody Drugs Amid Spike In Cases
The European Union drugs regulator is set to authorise the use of two monoclonal antibodies to treat COVID-19 patients in coming days, two EU sources told Reuters, in its first approvals of such therapies.
-
Pfizer Submits Data For Approval Of Covid Jab For Ages 5 To 11 In Europe
Pfizer and BioNTech said Friday they had submitted data to the EU's medicines watchdog for the approval of their coronavirus vaccine for children aged 5 to 11, following a similar step in the United States.
-
Nerve Disorder Listed As "Very Rare" Side Effect Of AstraZeneca Vaccine
The European Medicines Agency has listed the neurological disorder Guillain-Barre syndrome, which can cause temporary paralysis, as a "very rare" side effect of the AstraZeneca Covid-19 vaccine.
-
No Application Received For Covishield Authorisation, Says EU Medical Body
The European Medicines Agency (EMA) has not received any application from the Serum Institute of India for authorisation of Covishield, a COVID-19 vaccine.
